Cognito Therapeutics, Inc.
Cambridge, MA
Works in Hematology · Immunology · Neurology · Oncology · Psychiatry
Cognito Therapeutics, Inc. is a clinical trial sponsor based in Cambridge, MA. It has 2 active clinical trials with 462 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Cognito Therapeutics, Inc
Cognito Therapeutics, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 462 planned participants, in Hematology, Immunology, Neurology, Oncology and other areas. Since 2021 it has completed 1 trial and stopped 0 early.
Cognito Therapeutics, Inc is based in Cambridge, MA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Cognito Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-09.
Approve Suite is not affiliated with Cognito Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.